UPS has announced an expansion to its International Special Commodities programme which will allow customers to ship biological substances, dangerous goods in accepted quantities and shipments utilizing dry ice to more than 20 additional international destinations.
UPS states that it has expanded the service in direct response to a growing demand from biopharmaceutical manufacturers, diagnostics companies, laboratories and distributors to ship these specialized commodities when security, time and temperature control are a high priority.
“The UPS global transportation network has been enhanced to move biological specimens to and from more than 50 countries around the world,” said John Menna, UPS Vice President of global strategy, healthcare logistics. “The expanded programme was guided by our customers to include the locations that are most important to them.”
UPS is now able to pick up and deliver packages under regulation UN3373 (Biologic Substances, Category B, Diagnostic Specimen and Clinical Specimen) as well as UN1845 (Carbon Dioxide, solid or dry ice) in Australia, Bulgaria, Croatia, Estonia, India, Indonesia, Israel, Latvia, Lithuania, New Zealand, Panama, Romania, Russia, Saudi Arabia, Slovakia, Slovenia, South Africa, Taiwan, Turkey and Ukraine.
The world's largest collection of global supply chain intelligence